NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 143 filers reported holding NEKTAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $200,000 | -23.4% | 2,314 | -47.0% | 0.08% | -25.7% |
Q4 2017 | $261,000 | -1.5% | 4,366 | -60.5% | 0.11% | +0.9% |
Q3 2017 | $265,000 | +21.0% | 11,061 | -1.1% | 0.11% | +16.1% |
Q2 2017 | $219,000 | -17.4% | 11,181 | -1.1% | 0.09% | -48.9% |
Q1 2017 | $265,000 | +89.3% | 11,306 | -0.9% | 0.18% | +83.8% |
Q4 2016 | $140,000 | -33.0% | 11,414 | -6.4% | 0.10% | -22.7% |
Q3 2016 | $209,000 | +20.8% | 12,189 | +0.4% | 0.13% | +14.3% |
Q2 2016 | $173,000 | +9.5% | 12,135 | +5.7% | 0.11% | +4.7% |
Q1 2016 | $158,000 | -27.5% | 11,485 | -11.0% | 0.11% | -25.2% |
Q4 2015 | $218,000 | +53.5% | 12,910 | -0.2% | 0.14% | +52.1% |
Q3 2015 | $142,000 | -10.1% | 12,940 | +2.2% | 0.09% | -7.8% |
Q2 2015 | $158,000 | +11.3% | 12,660 | -2.1% | 0.10% | +15.9% |
Q1 2015 | $142,000 | -29.0% | 12,925 | +0.3% | 0.09% | -31.2% |
Q4 2014 | $200,000 | -9.1% | 12,885 | -29.4% | 0.13% | -6.6% |
Q3 2014 | $220,000 | -4.8% | 18,250 | +1.2% | 0.14% | -1.4% |
Q2 2014 | $231,000 | +5.5% | 18,040 | -0.3% | 0.14% | +0.7% |
Q1 2014 | $219,000 | +5.8% | 18,100 | -0.8% | 0.14% | +0.7% |
Q4 2013 | $207,000 | +8.9% | 18,250 | +0.5% | 0.14% | -2.1% |
Q3 2013 | $190,000 | -10.4% | 18,160 | -0.9% | 0.14% | -15.7% |
Q2 2013 | $212,000 | – | 18,320 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |